Inspiration Healthcare Group PLC Mello investor conference

TIDMIHC

Inspiration Healthcare Group PLC

17 May 2023

17 May 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Mello investor conference

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that they will be attending the Mello2023 investor conference on Wednesday, 24 May. The conference will take place at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY.

Neil Campbell, CEO of Inspiration Healthcare Group plc will be presenting on the day. The Company will also have an exhibition stand, giving investors the opportunity for discussions with the management.

   Investors wishing to attend can find more details at   www.melloevents.com . 

For further information:

 
Inspiration Healthcare Group plc                                                      Tel: [phone] 
Neil Campbell, Chief Executive Officer 
Paul Bergin, Interim Chief Financial Officer 
 
Cenkos Securities plc (Nominated Adviser                                              Tel: [phone] 
 & Broker) 
Stephen Keys, Katy Birkin, Dan Hodkinson 
 
Walbrook PR Ltd (Media and Investor           Tel: [phone] or [e-mail] 
 Relations) 
Anna Dunphy                                                                          Mob: [phone] 
Stephanie Cuthbert                                                                   Mob: [phone] 
Louis Ashe-Jepson                                                                    Mob: [phone] 
 
 

About Inspiration Healthcare Group plc

Inspiration Healthcare Group plc (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFLFSEETIRLIV

(END) Dow Jones Newswires

May 17, 2023 02:00 ET (06:00 GMT)